A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
NCT06697600 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1020
Last updated 2026-03-31
Summary
This is a multicenter randomized controlled trial that assesses the efficacy of a decisional intervention \[University of Rochester-Geriatric Oncology assessment for Acute myeloid Leukemia (UR-GOAL)\] compared to an attention control.
Conditions
Interventions
- BEHAVIORAL
-
UR-GOAL
Patients will view an AML video, complete the best/worst scaling, will be provided with a summary report, and will be asked to review and discuss at upcoming clinical visits. Caregivers, if available, will view an AML video, will be provided with a summary report, and will be asked to review. Oncologists will be provided with a summary report and will be asked to review and discuss at upcoming clinical visits.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Rochester
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-11
- Primary Completion
- 2029-10-01
- Completion
- 2030-06-01
Countries
- United States
Study Locations
More Related Trials
-
Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome
NCT02670525 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
NCT05433090 ·Status: COMPLETED ·Phase: NA
-
Psychological Intervention Mobile App for Patients With AML
NCT03372291 ·Status: COMPLETED ·Phase: NA
-
Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia
NCT04158726 ·Status: COMPLETED ·Phase: NA
-
Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories
NCT07263074 ·Status: RECRUITING ·Phase: NA
-
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
NCT00002766 ·Status: COMPLETED ·Phase: PHASE3
-
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
NCT01420926 ·Status: COMPLETED ·Phase: PHASE2
-
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
NCT00091234 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
NCT00006122 ·Status: COMPLETED ·Phase: PHASE2
-
Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy
NCT06130787 ·Status: RECRUITING ·Phase: NA
-
Quality of Life Model for Older Patients With AML
NCT04380441 ·Status: ACTIVE_NOT_RECRUITING
-
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
NCT07094750 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75
NCT03902665 ·Status: COMPLETED ·Phase: PHASE2
-
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
NCT00742625 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
NCT03701308 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
NCT00052299 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia
NCT04885127 ·Status: COMPLETED ·Phase: NA
-
Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT00844441 ·Status: COMPLETED ·Phase: NA
-
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072 ·Status: COMPLETED ·Phase: PHASE2
-
Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival
NCT01188330 ·Status: UNKNOWN ·Phase: NA
-
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.
NCT03350152 ·Status: COMPLETED
-
Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AML
NCT03620955 ·Status: UNKNOWN
-
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
NCT00002514 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
NCT00003700 ·Status: COMPLETED ·Phase: PHASE2